Curia finalizes LakePharma acquisition

By The Science Advisory Board staff writers

September 3, 2021 -- Curia has finalized its acquisition of LakePharma, a privately held biologics drug discovery, clinical research, and manufacturing organization.

With the acquisition, Curia, formerly known as Albany Molecular Research, said it can offer its expertise in both large and small molecules throughout each stage of the drug discovery and manufacturing process, including sterile injectable formulation and fill-finish production.

LakePharma will operate as part of Curia's R&D division. LakePharma and its "the biologics company" brand will migrate to Curia.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.